that severely impacts lung function. Novel 2-sulfonylindoles were recently shown to exhibit anti-inflammatory activity through the inhibition of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) production. Here, we synthesized 31 compounds which contained 2-sulfonylindole structure. The compounds 8a, 9g, 9h and 9k exhibited dose-dependent anti-inflammatory activity in vitro. Structural-activity
急性肺损伤(ALI)主要由严重影响肺功能的炎症驱动。最近显示,新型2-磺酰
吲哚类通过抑制肿瘤坏死因子-α(TNF-α)和白介素-6(IL-6)的产生表现出抗炎活性。在这里,我们合成了31种含有2-磺酰基
吲哚结构的化合物。化合物8a,9g,9h和9k在体外表现出剂量依赖性的抗炎活性。结构-活性关系分析表明,磺酰基在
吲哚核中的引入可能成功获得了新的抗炎结构和新的线索。化合物9h和9k在ALI的体外和体内模型中,脂蛋白(LPS)诱导的IL-6,IL-1β和血管细胞粘附分子1(VCAM-1)mRNA表达也降低。此外,高剂量(20 mg / kg)的化合物9h和9k显着保护了小鼠免受LPS诱导的ALI侵害。这些结果表明,化合物9h和9k可能是治疗ALI的有前途的先导结构。